Also trades as: CMRAW (NASDAQ) · $vol 0M

$0.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $3074 mcap · 14M float · 0.0070% daily turnover

Revenue

$633K +97.9% ▲

Gross Profit

$423K +166.2% ▲

Operating Income

-$12M -116.2% ▼

Net Income

-$18M -230.2% ▼

EPS (Diluted)

$-1.76 -506.9% ▼

EBITDA

-$18M -233.4% ▼

View Full Income Statement

Line Item	FY2020	FY2021	FY2022
Revenue	$443K	$320K	$633K
YoY Growth	+0.0%	-27.8%	+97.9%
Cost of Revenue	$104K	$161K	$210K
Gross Profit	$339K	$159K	$423K
Gross Margin	76.4%	49.7%	66.8%
R&D Expenses	$1M	$2M	$2M
SG&A Expenses	$1M	$4M	$11M
Operating Expenses	$2M	$6M	$12M
Operating Income	-$2M	-$6M	-$12M
Operating Margin	-480.3%	-1730.8%	-1890.7%
Interest Expense	$0	$0	$20K
Income Before Tax	-$2M	-$5M	-$18M
Tax Expense	$0	$0	$0
Net Income	-$2M	-$5M	-$18M
Net Margin	-479.9%	-1704.6%	-2843.8%
EPS (Diluted)	$-0.11	$-0.29	$-1.76
EBITDA	-$2M	-$5M	-$18M
Shares Outstanding	19M	19M	10M

Line Item	FY2021 Q4	FY2022 Q1	FY2022 Q2	FY2022 Q3	FY2022 Q4	FY2023 Q1	FY2023 Q2	FY2023 Q3
Revenue	$73K	$95K	$147K	$235K	$156K	$393K	$315K	$136K
Cost of Revenue	$39K	$45K	$55K	$61K	$50K	$117K	$56K	$42K
Gross Profit	$34K	$51K	$92K	$174K	$106K	$276K	$259K	$94K
Gross Margin	46.9%	53.3%	62.8%	74.0%	67.7%	70.3%	82.2%	69.2%
R&D Expenses	$490K	$487K	$369K	$395K	$489K	$344K	$236K	$366K
SG&A Expenses	$2M	$2M	$4M	$2M	$3M	$2M	$2M	$2M
Operating Expenses	$2M	$3M	$4M	$3M	$3M	$3M	$2M	$2M
Operating Income	-$2M	-$2M	-$4M	-$3M	-$3M	-$3M	-$1M	-$2M
Operating Margin	-2760.1%	-2572.7%	-2707.7%	-1079.2%	-1927.4%	-636.4%	-469.8%	-1582.5%
Interest Expense	$0	$77	$0	$13K	$8K	$8K	$4K	$6K
Income Before Tax	-$2M	-$3M	-$9M	-$3M	-$3M	-$2M	-$1M	-$2M
Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$2M	-$3M	-$9M	-$3M	-$3M	-$2M	-$1M	-$2M
Net Margin	-2760.1%	-3020.3%	-6192.0%	-1309.7%	-1897.6%	-631.5%	-448.1%	-1580.0%
EPS (Diluted)	$-0.11	$-0.15	$-1.14	$-0.20	$-0.18	$-0.13	$-0.08	$-0.10
EBITDA	-$2M	-$3M	-$9M	-$3M	-$3M	-$2M	-$1M	-$2M
Shares Outstanding	19M	19M	8M	16M	17M	19M	19M	23M

CMRA OTC